- 2021 - 2024 COVID-19に対する可溶性ULBP2制御によるNK細胞療法の開発
- 2020 - 2024 非結核性抗酸菌症と腸内細菌叢の関わりについて
- 2018 - 2021 Development of a novel surveillance system integrating local and global AMR information
- 2014 - 2018 Development of the new clinical cure to overcome pemetrexed tolerance for malignant pleural mesothelioma
- 2014 - 2018 A novel therapy for sepsis by regulating soluble ULBP2
- 2011 - 2015 Molecular biological influence of sleep apnea syndrome on circadian clock system
- 2010 - 2012 Development of novel therapy for malignant mesothelioma by controllingADCC activity.
- 2009 - 2011 Development of novel biomarker for cetuximab therapy in lung cancer
- 2008 - 2010 Influence of sleep apnea syndrome on clock gene dysfunction
- 2005 - 2006 Clock gene dysfunction in patients with obstructive sleep apnea syndrome
- 2003 - 2005 Analysis of activation mechanisms of Rho and RhoGEFs as a new molecular target for lung cancer therapy.
- 2002 - 2003 Measurement of antibodies against tumor suppressor gene products in health screening for lung cancer
- 1998 - 1999 Development and clinical utility of membrane humidifier without need of water for humidification
Show all